CPAP for the metabolic syndrome in patients with obstructive sleep apnea (Q48269770)

10 February 2018

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

CPAP for the metabolic syndrome in patients with obstructive sleep apnea (English)

1 reference

10 February 2018

0 references

1 reference

Surendra K Sharma

1

1 reference

10 February 2018

Swastik Agrawal

2

1 reference

10 February 2018

Deepak Damodaran

3

1 reference

10 February 2018

Vishnubhatla Sreenivas

4

1 reference

10 February 2018

Tamilarasu Kadhiravan

5

1 reference

10 February 2018

Ramakrishnan Lakshmy

6

1 reference

10 February 2018

Priya Jagia

7

1 reference

10 February 2018

Atin Kumar

8

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 December 2011

1 reference

10 February 2018

The New England Journal of Medicine

published in

1 reference

10 February 2018

volume

365

1 reference

10 February 2018

issue

24

1 reference

10 February 2018

page(s)

2277-2286

1 reference

10 February 2018

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

cites work

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1056/NEJMOA1103944

Obesity, and not obstructive sleep apnea, is responsible for metabolic abnormalities in a cohort with sleep-disordered breathing

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1056/NEJMOA1103944

Effects of nasal CPAP treatment on insulin resistance, lipid profile, and plasma leptin in sleep apnea

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1056/NEJMOA1103944

Obstructive sleep apnea is independently associated with insulin resistance.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1056/NEJMOA1103944

Cardiovascular and metabolic effects of CPAP in obese males with OSA.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1056/NEJMOA1103944

Effect of continuous positive airway pressure on ambulatory BP in patients with sleep apnea and hypertension: a placebo-controlled trial.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1056/NEJMOA1103944

Obstructive sleep apnoea and its therapy influence high-density lipoprotein cholesterol serum levels

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1056/NEJMOA1103944

A stepped approach for prediction of obstructive sleep apnea in overtly asymptomatic obese subjects: a hospital based study

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1056/NEJMOA1103944

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1056/NEJMOA1103944

Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1056/NEJMOA1103944

The occurrence of sleep-disordered breathing among middle-aged adults

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1056/NEJMOA1103944

Continuous positive airway pressure treatment in sleep apnea patients with resistant hypertension: a randomized, controlled trial

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1056/NEJMOA1103944

Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1056/NEJMOA1103944

Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1056/NEJMOA1103944

Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1056/NEJMOA1103944

Prevalence and risk factors of syndrome Z in urban Indians

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1056/NEJMOA1103944

Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1056/NEJMOA1103944

Sleep oxygen desaturation and circulating leptin in obstructive sleep apnea-hypopnea syndrome

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1056/NEJMOA1103944

Blood pressure, stroke, and coronary heart disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1056/NEJMOA1103944

Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1056/NEJMOA1103944

Estimation of LDL cholesterol based on the Friedewald formula and on apo B levels

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1056/NEJMOA1103944

Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1056/NEJMOA1103944

Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1056/NEJMOA1103944

Metabolic abnormalities in obesity and sleep apnea are in a continuum

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1056/NEJMOA1103944

Continuous positive airway pressure as treatment for systemic hypertension in people with obstructive sleep apnoea: randomised controlled trial.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1056/NEJMOA1103944

A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1056/NEJMOA1103944

Prevalence and risk factors of obstructive sleep apnea syndrome in a population of Delhi, India

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1056/NEJMOA1103944

Abdominal fat: standardized technique for measurement at CT.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1056/NEJMOA1103944

Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1056/NEJMOA1103944

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1056/NEJMOA1103944

Effect of continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1056/NEJMOA1103944

Identifiers

DOI

10.1056/NEJMOA1103944

1 reference

10 February 2018

1 reference

10 February 2018